A real‐world study on the prevalence and risk factors of medication related osteonecrosis of the jaw in cancer patients with bone metastases treated with Denosumab

Abstract Aim Assessing the incidence of Medication Related Osteonecrosis of the Jaw (MRONJ) in cancer patients with bone metastases receiving Denosumab (Dmab) and identifying potential risk factors. Methods A retrospective observational study on consecutive cancer patients with bone metastases, who...

Full description

Bibliographic Details
Published in:	Cancer Medicine
Main Authors:	Paola Bracchi, Ernesto Zecca, Cinzia Brunelli, Rosalba Miceli, Gabriele Tinè, Massimo Maniezzo, Silvia Lo Dico, Mariangela Caputo, Morena Shkodra, Augusto T. Caraceni
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Subjects:	bone metastasis cancer Denosumab osteonecrosis of the jaw risk factors
Online Access:	https://doi.org/10.1002/cam4.6429

Similar Items

ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Osteonecrosis of jaw associated with bisphosphonate use
by: Ashu Rastogi, et al.
Published: (2012-01-01)

Denosumab-associated jaw bone necrosis in cancer patients: retrospective descriptive case series study
by: Ji-Yeon Kang, et al.
Published: (2023-06-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw
by: Sandra Bacián Martínez, et al.
Published: (2021-08-01)

Temporary Denosumab Discontinuation Promotes Bone Healing of Osteonecrosis of the Jaw and Minimizes the Invasiveness of Surgery: A Case Presentation
by: Giordana Bettini, et al.
Published: (2022-02-01)

RANK-Ligand inhibitor associated osteonecrosis of the jaw
by: Rashad, Ashkan, et al.
Published: (2013-11-01)

Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01)

Sarcopenia as a Potential Risk Factor for Denosumab-Related Osteonecrosis of the Jaw in Asian Prostate Cancer Patients with Bone Metastases
by: Shinobu Mizushima, et al.
Published: (2025-10-01)

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy
by: Derek Oryniak, et al.
Published: (2024-07-01)

Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
by: SALONI RAJKOTIA, et al.
Published: (2024-11-01)

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management
by: Masaru Tani, et al.
Published: (2024-06-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Medication-related osteonecrosis of the jaw: Prosthodontic considerations
by: Islam E. Ali, et al.
Published: (2022-11-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
by: Dora Karimi, et al.
Published: (2024-09-01)

Bone Targeting Agents in Patients with Prostate Cancer: General Toxicities and Osteonecrosis of the Jaw
by: Veronica Mollica, et al.
Published: (2022-03-01)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
by: Masanori Nashi, et al.
Published: (2023-07-01)

Effects of discontinuing different antiresorptive regimens on medication-related osteonecrosis of the jaw in patients undergoing dental procedures: a systematic review and network meta-analysis
by: Kasidid Ruksakiet, et al.
Published: (2025-05-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Torus palatinus osteonecrosis: A hitherto unreported complication of long-term Denosumab use
by: Kendal L. Weger, MD, et al.
Published: (2025-01-01)

Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases
by: Youngmin Kwon, et al.
Published: (2023-04-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

Associated systemic diseases and etiologies of medication-related osteonecrosis of the jaw: a retrospective study of 265 surgical cases
by: Hoon-Je Chang, et al.
Published: (2023-02-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

Drug holiday of high-dose denosumab and recovery from osteoclast inhibition using immunohistochemical investigation of 7 patients with medication-related osteonecrosis of the jaw undergoing segmental mandibulectomy
by: Shunsuke Sawada, et al.
Published: (2023-10-01)

Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study
by: Keisuke Seki, et al.
Published: (2022-10-01)

A case series and review of canine idiopathic osteonecrosis of the jaw
by: Amy Rossi, et al.
Published: (2025-05-01)

Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
by: E. M. Spevak, et al.
Published: (2022-07-01)

Drug-induced osteonecrosis of the jaw: the state of the art
by: A. Fassio, et al.
Published: (2017-05-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Clinical study of bisphosphonate⁃related osteonecrosis of the jaws
by: WU Yu⁃ling, et al.
Published: (2017-01-01)